Sonoma Pharmaceuticals, Inc.
SNOA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001367083
No open-market purchases or sales by Sonoma Pharmaceuticals, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $136.3K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Sonoma Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 14 | 20 | +6 |
| Shares | 84.9K | 59.4K | −25.5K (−30.1%) |
| Value | $242.0K | $230.3K | −$11.7K (−4.8%) |
New holders (8)
Institutions that held Sonoma Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 20,873 | $81.0K | 0.00% |
| DRW Securities, LLC | 17,070 | $66.2K | 0.00% |
| Citigroup Inc | 656 | $2.54K | 0.00% |
| Rockefeller Capital Management L.P. | 646 | $2.51K | 0.00% |
| Global Retirement Partners, LLC | 438 | $1.70K | 0.00% |
| MAI Capital Management | 124 | $482 | 0.00% |
| FMR LLC | 2 | $7 | 0.00% |
| SBI Securities Co., Ltd. | 1 | $4 | 0.00% |
Sold out (2)
Institutions that held Sonoma Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Heron Bay Capital Management | 33,782 | $96.1K |
| Renaissance Technologies LLC | 17,800 | $50.6K |